| QRS-Area (µVs) | QRS Duration (ms) | QRS Amplitude (mV) |
---|---|---|---|
β (95%CI); p-value | β (95%CI); p-value | β (95%CI); p-value | |
Model 1: Crude | Â | Â | Â |
 Tertile 1 (reference) | – | – | – |
 Average difference tertile 2 |  − 0.84 (− 6.13; 4.44); 0.753 | 4.45 (− 3.02; 11.93); 0.242 |  − 0.05 (− 0.18; 0.08); 0.447 |
 Interaction tertile 2 and time (days) |  − 0.05 (− 0.20; 0.10); 0.527 | 0.00 (− 0.24; 0.24); 0.982 | 0.00 (− 0.00; 0.01); 0.601 |
 Average difference tertile 3 | 6.65 (1.50; 11.81); 0.012* | 12.02 (4.74; 19.30); 0.001* | 0.07 (− 0.05; 0.19); 0.271 |
 Interaction tertile 3 and time (days) |  − 0.27 (− 0.43; − 0.11); 0.001* | 0.04 (− 0.21; 0.29); 0.738 |  − 0.01 (− 0.01; − 0.00); 0.029* |
Model 2: Model 1 adjusted for age, sex, and APACHE − II score | |||
 Tertile 1 (reference) | – | – | – |
 Average difference tertile 2 | 0.56 (− 5.03; 6.15); 0.844 |  − 0.45 (− 7.87; 6.96); 0.904 | 0.02 (− 0.11; 0.15); 0.777 |
 Interaction tertile 2 and time (days) |  − 0.05 (− 0.20; 0.10); 0.533 | 0.00 (− 0.23; 0.24); 0.985 | 0.00 (− 0.00; 0.01); 0.563 |
 Average difference tertile 3 | 8.50 (2.69; 14.30); 0.004* | 6.07 (− 1.53; 13.67); 0.118 | 0.16 (0.02; 0.30); 0.023* |
 Interaction tertile 3 and time (days) |  − 0.27 (− 0.43; − 0.11); 0.001* | 0.04 (− 0.21; 0.29); 0.772 |  − 0.01 (− 0.01; − 0.00); 0.038* |
Model 3: Model 2 adjusted for chronic lung disease and liver conditions | |||
 Tertile 1 (reference) | – | – | – |
 Average difference tertile 2 | 0.55 (− 5.10; 6.19); 0.849 |  − 0.30 (− 7.78; 7.18); 0.937 | 0.02 (− 0.11; 0.16); 0.717 |
 Interaction tertile 2 and time (days) |  − 0.05 (− 0.20; 0.10); 0.533 | 0.00 (− 0.24; 0.24); 1.000 | 0.00 (− 0.00; 0.01); 0.542 |
 Average difference tertile 3 | 8.26 (2.46; 14.05); 0.006* | 6.31 (− 1.31; 13.93); 0.105 | 0.16 (− 0.02; 0.29); 0.025* |
 Interaction tertile 3 and time (days) |  − 0.27 (− 0.43; − 0.11); 0.001* | 0.03 (− 0.22; 0.28); 0.804 |  − 0.01 (− 0.01; 0.00); 0.040* |